Close

Authors

Featured Authors

Nigel has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product developm...
Professor Neil A. Williams, CSO at KWS BioTest, commented: “The recognition that some conventional and new cancer therapies can enhance recognition of cancer cells by the immune system points toward...

Daniel Tedham

, The Wasdell Group
The pharma sector has shifted from traditional stockpiling and large batch manufacturing to bespoke and specific production to meet the requirements of individual products and the markets and patients...
Laboratory Manager for SCHOTT pharma services, earned his diploma degree in Biotechnology with focus on Analytical Chemistry at the University of applied sciences in Darmstadt. He joined SCHOTT in 201...
Director of SCHOTT pharma services earned his doctorate in Physics at the University of Kaiserslautern in Germany. He joined SCHOTT in 2000 and focused his activities on analytical support around glas...
Scientific Advisor for SCHOTT pharma services, earned his doctorate in Inorganic Chemistry at the University of Chicago. He joined SCHOTT in 2001 with a focus on developing glass coatings to control d...

Brian Daleiden

, TraceLink
Brian is at the helm of TraceLink’s thought leadership, global regulatory analysis, and market education programs which serve to inform and guide internal industry stakeholders about emerging and on...

Rick Seibert

, Sharp
Rick has over 20 years’ experience, and is our Senior Vice President of Project Management & Technology Services. He joined Sharp in 2004 after holding senior roles at B. Braun Medical. Rick has...

Marie-Pierre PASDELOU

, CILcare Inc
Marie-Pierre Pasdelou, PharmD, is a founder and the Chief Development Officer of CILcare, the world-leading services company for drug development in hearing and otic disorders, with unique know-how fo...

Chris Rivera

, Nativis Inc
Rivera has more than 30 years of experience in the biotechnology industry. He was founder and CEO of Hyperion Therapeutics, which was acquired by Horizon Pharma; and Senior Vice President at both Terc...